Therapeutic efficacy of sequential therapy with OK-432, cyclophosphamide, IL2-cultured lymphocytes and in vivo IL2 against advanced murine plasmacytoma.

Source:http://linkedlifedata.com/resource/pubmed/id/2642023

Download in:

View as

General Info

PMID
2642023